A high phylloquinone intake is required to achieve maximal osteocalcin γ-carboxylation

American Journal of Clinical Nutrition

Volumn 76, Issue 5, 2002, Pages 1055-1060

  Binkley, Neil C ^a,c   Krueger, Diane C ^a   Kawahara, Tisha N ^a   Engelke, Jean A ^b   Chappell, Richard J ^b   Suttie, John W ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NONE   (United States)

Author keywords

Osteocalcin; Phylloquinone; Undercarboxylated osteocalcin; Vitamin K; carboxylation

Indexed keywords

OSTEOCALCIN; PHYTOMENADIONE; VITAMIN K GROUP;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNORADIOMETRIC ASSAY; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0036828351     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/76.5.1055     Document Type: Article

References (41)

1. Suttie JW. Warfarin and vitamin K. Clin Cardiol 1990;13:16-8.
2. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999;93:1798-808.
3. Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 1996;63:566-73.
4. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA. Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 1997;65:779-84.
5. Jie KS, Hamulyak K, Gijsbers BL, Roumen FJ, Vermeer C. Serum osteocalcin as a marker for vitamin K-status in pregnant women and their newborn babies. Thromb Haemost 1992;68:388-91.
6. Binkley NC, Krueger DC, Engelke JA, Foley AL, Suttie JS. Vitamin K supplementation reduces serum concentrations of under-gamma-caraboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr 2000;72:1523-8.
7. Rucker RB. Improved functional endpoints for use in vitamin K assessment: Important implications for bone disease. Am J Clin Nutr 1997;65:883-4.
8. Esmon CT, Suttie JW, Jackson CM. The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin. J Biol Chem 1975;250:4095-9.
9. Binkley NC, Suttie JW. Vitamin K nutrition and osteoporosis. J Nutr 1995;125:1812-21.
10. Booth SL, Gundberg CM, McKeown NM, Morse MO, Wood RJ. Vitamin K depletion increases bone turnover. J Bone Miner Res 1999;14(suppl):S393 (abstr).
11. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-52.
12. Weber P. The role of vitamins in the prevention of osteoporosis - A brief status report. Int J Vitam Nutr Res 1999;69:194-9.
13. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: A prospective study. Am J Clin Nutr 1999;69:74-9.
14. Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000;71:1201-8.
15. Jamal SA, Browner WS, Bauer DC, Cummings SR. Warfarin use and risk for osteoporosis in elderly women. Ann Intern Med 1998;128:829-32.
16. Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ, Melton LJ. Changes in bone density after exposure to oral anticoagulants: A meta-analysis. Osteoporos Int 1999;9:441-8.
17. Caraballo PJ, Heit JA, Atkinson EJ, et al. Long-term use of oral anti-coagulants and the risk of fracture. Arch Intern Med 1999;159:1750-6.
18. Rosen HN, Maitland LA, Suttie JW, Manning WJ, Glynn RJ, Greenspan SL. Vitamin K and maintenance of skeletal integrity in adults. Am J Med 1993;94:62-8.
19. 1 treatment. In: Christiansen C, Overgaard K, eds. Osteoporosis. Copenhagen: Osteopress, 1990:345-7.
20. Knapen MHJ, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 1989;111:1001-5.
21. Knapen MH, Jie KS, Hamulyak K, Vermeer C. Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss. Calcif Tissue Int 1993;53:81-5.
22. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS study. J Clin Endocrinol Metab 1997;82:719-24.
23. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994;9:1591-5.
24. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1769-74.
25. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study. Bone 1996;18:487-8.
26. Booth SL, Pennington JAT, Sadowski JA. Food sources and dietary intakes of vitamin K-1 (phylloquinone) in the American diet: Data from the FDA total diet study. J Am Diet Assoc 1996;96:149-54.
27. Price PA, Epstein DJ, Lothringer JW, Nishimoto SK, Poser JW, Williamson MK. Structure and function of the vitamin K-dependent protein of bone. In: Suttie JW, ed. Vitamin K Metabolism and Vitamin K-Dependent Proteins. Baltimore: University Park Press, 1980:219-26.
28. 1 in plasma with fluorometric detection. Clin Chem 1986;32:1925-9.
29. Armitage P, Colton T, eds. The Encyclopedia of Biostatistics. New York: Wiley, 1998.
30. Garber AK, Binkley NC, Krueger DC, Suttie JW. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. J Nutr 1999;129:1201-3.
31. Gijsbers BLM, Jie KS, Vermeer C. Effect of food composition on vitamin K absorption in human volunteers. Br J Nutr 1996;76:223-9.
32. Booth SL, O'Brien-Morse ME, Dallal GE, Davidson KW, Gundberg CM. Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: Comparison of younger and older adults. Am J Clin Nutr 1999;70:368-77.
33. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr 1998;128:785-8.
34. Shearer MJ, Harvey JM, Mole P, McMurdo MET, Paterson CR, Bolton-Smith C. Can Increased Dietary Intakes of Vitamin K Help to Prevent Osteoporosis? An Ongoing Intervention Trial in the UK. Osteoporosis and Vitamin K. Seoul, Korea: Intermedd Inc, 1999:20-3.
35. Douglas AS, Robins SP, Hutchison JD, Poter RW, Stewart A, Reid DM. Carboxylation of osteocalcin in postmenopausal osteoporotic women following vitamin K and D supplementation. Bone 1995;17:15-20.
36. Jie KS, Gijsbers BL, Knapen MH, Hamulyak K, Frank HL, Vermeer C. Effects of vitamin K and oral anticoagulants on urinary calcium excretion. Br J Haematol 1993;83:100-4.
37. Craciun AM, Wolf J, Knapen MH, Brouns F, Vermeer C. Improved bone metabolism in female elite athletes after vitamin K supplementation. Int J Sports Med 1998;19:479-84.
38. Orimo H, Shiraki M, Fujita T, Onomura T, Inoue T, Kushida K. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis - A double-blind multicenter comparative study with 1α hydroxyvitamin D. J Bone Miner Res 1992;7:S122 (abstr).
39. Orimo H, Shiraki M, Tomita A, Morii H, Fujita T, Ohata M. Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study. J Bone Miner Metab 1998;16:106-12.
40. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000;15:515-21.
41. Thurman JE, Mooradian AD. Vitamin supplementation therapy in the elderly. Drugs Aging 1997;11:433-49.